Drug development is dynamic and engages CMC regulatory input at each step. It’s common to focus on the high-level, current tasks, without thinking more holistically about the CMC regulatory process and your molecule’s lifecycle. With a high-level focus, important steps and regulatory requirements are often missed, which can cause lengthy delays or additional costs to your project. As a result, it’s important to proactively plan and develop CMC regulatory strategies early on in your development process.

Attend this webinar to learn more about:

• Navigating a variety of regulatory CMC issues in product development to ensure market application readiness
• Key considerations for product development to ensure global CMC requirements are met for clinical trial and marketing applications
• Regional specific CMC data to support clinical trials for key countries: US, EU, UK, Australia, Canada and China